Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin Regimen for Patients Infected with Chronic Hepatitis C Virus Genotype 1 in Malaysia
Clicks: 236
ID: 92158
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
78.3
/100
236 views
189 readers
Trending
AI Quality Assessment
Not analyzed
| Reference Key |
shafie2020costeffectivenessvalue
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Shafie, A. |
| Journal | value in health regional issues |
| Year | 2020 |
| DOI | 10.1016/j.vhri.2019.09.005 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.